SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-101634
Filing Date
2022-09-20
Accepted
2022-09-20 17:23:42
Documents
12
Period of Report
2022-09-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2226320d1_8k.htm   iXBRL 8-K 28939
  Complete submission text file 0001104659-22-101634.txt   200356

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA armp-20220920.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20220920_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20220920_pre.xml EX-101.PRE 22603
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2226320d1_8k_htm.xml XML 3474
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 221254522
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences